DAB2IP and breast cancer: A recent study found that DAB2IP can modulate glucose metabolism during hypoxia by promoting degradation of HIF-1α; in breast cancer cells cultured in low oxygen, DAB2IP depletion increased glucose uptake, lactate production, and intracellular ATP levels, while DAB2IP overexpression had opposite effects [24].